pI: 8.1969 |
Length (AA): 271 |
MW (Da): 30896 |
Paralog Number:
11
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129108)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G34150 | calcium-dependent lipid-binding domain-containing protein |
Dictyostelium discoideum | DDB_G0294603 | C2 domain-containing protein |
Dictyostelium discoideum | DDB_G0278101 | C2 domain-containing protein |
Dictyostelium discoideum | DDB_G0272734 | hypothetical protein |
Dictyostelium discoideum | DDB_G0290755 | C2 domain-containing protein |
Dictyostelium discoideum | DDB_G0279935 | hypothetical protein |
Dictyostelium discoideum | DDB_G0290753 | C2 domain-containing protein |
Dictyostelium discoideum | DDB_G0272752 | C2 domain-containing protein |
Entamoeba histolytica | EHI_118130 | C2 domain containing protein |
Entamoeba histolytica | EHI_059860 | C2 domain containing protein |
Entamoeba histolytica | EHI_015290 | C2 domain protein, putative |
Leishmania braziliensis | LbrM.31.0850 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.31.0970 | c2 domain protein, putative |
Leishmania donovani | LdBPK_310710.1 | C2 domain containing protein, putative |
Leishmania donovani | LdBPK_310820.1 | c2 domain protein, putative |
Leishmania infantum | LinJ.31.0820 | c2 domain protein, putative |
Leishmania infantum | LinJ.31.0710 | hypothetical protein, conserved |
Leishmania major | LmjF.31.0790 | c2 domain protein, putative |
Leishmania major | LmjF.31.0680 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.30.0680 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.30.0790 | c2 domain protein, putative |
Neospora caninum | NCLIV_065990 | C2 domain-containing protein, putative |
Neospora caninum | NCLIV_022080 | hypothetical protein |
Oryza sativa | 4337436 | Os04g0682100 |
Trypanosoma brucei gambiense | Tbg972.8.8470 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.8150 | C2 domain containing protein, putative |
Trypanosoma congolense | TcIL3000_0_20280 | C2 domain containing protein, putative |
Trypanosoma congolense | TcIL3000_4_3610 | C2 domain containing protein, putative |
Trypanosoma congolense | TcIL3000_8_8300 | C2 domain containing protein, putative |
Trypanosoma cruzi | TcCLB.460747.30 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509895.60 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_249870 | hypothetical protein |
Toxoplasma gondii | TGME49_202830 | Elicitor-responsive protein, putative |
Trichomonas vaginalis | TVAG_193820 | Circumsporozoite protein precursor, putative |
Trichomonas vaginalis | TVAG_000170 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_444780 | Proline-rich protein, putative |
Trichomonas vaginalis | TVAG_215950 | synaptotagmin, putative |
Trichomonas vaginalis | TVAG_002900 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_347440 | annexin VII, putative |
Trichomonas vaginalis | TVAG_145560 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_041990 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_063200 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_456580 | splicing factor 3A subunit, putative |
Trichomonas vaginalis | TVAG_292610 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_024730 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.8150 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.8150 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.8150 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.8150 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_202830 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_249870 | Toxoplasma gondii | Probably non-essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.